(Q34135239)

31 July 2017

Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy (English)

1 reference

31 July 2017

Ana Ramírez de Molina

1

1 reference

31 July 2017

Ruth Gutiérrez

2

1 reference

31 July 2017

Maria Angeles Ramos

3

1 reference

31 July 2017

José María Silva

4

1 reference

31 July 2017

Javier Silva

5

1 reference

31 July 2017

Félix Bonilla

6

1 reference

31 July 2017

José Javier Sánchez

7

1 reference

31 July 2017

Juan Carlos Lacal

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

31 July 2017

1 reference

31 July 2017

21

1 reference

31 July 2017

4317-4322

1 reference

31 July 2017

27

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205556

31 July 2017

0 references

cites work

Future prospects for the prevention and cure of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Choline kinase inhibitors as a novel approach for antiproliferative drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Statistical approaches to the analysis of receiver operating characteristic (ROC) curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

Clinicopathological characteristics of breast carcinomas with allelic loss in the p73 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

7 January 2021

Phospholipid metabolites, prognosis and proliferation in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

7 January 2021

Activated oncogenes and putative tumor suppressor genes involved in human breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205556

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205556

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference